Advertisement

Bahrain Follows UK Permits The Use Of Pfizer-BioNTech Vaccine

Pfizer corona vaccine

Pfizer corona vaccine

Advertisement

As per the reports, Bahrain is the second country in the world to permit the use of the country’s Pfizer/BioNTech coronavirus vaccine.

On Friday, the state-run media announced that that the approval was granted after a detailed examination and evaluation of the available data by the National Health Regulatory Authority (NHRA) of Bahrain.

Dr. Mariam Al Jalahma CEO of NHRA said “The approval of the Pfizer/BioNTech vaccine will add a further important layer to the Kingdom’s national COVID-19 response, which has strongly prioritized protecting the health of all citizens and residents during the pandemic.”

However, Lindsey Dietschi, the Gulf Cluster Lead of Pfizer was quoted by BNA as a “historic moment in the fight against COVID-19”.

“This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the National Health Regulatory Authority in the kingdom of Bahrain for their ability to conduct a careful assessment and take timely action to help protect the people of Bahrain,” says Dietschi

Advertisement

Moreover, the Kingdom also permitted the application of Sinopharm for its health workers last month.


Also Read

How will Pfizer/BioNTech be used next week?

The UK has become the first country to approve Pfizer/BioNTech coronavirus vaccine...

Advertisement
Read More News On

Catch all the Business News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Live News.


Advertisement
End of Story
BOL Stories of the day
Karachi reports first case of Congo virus
Another Congo virus patient from Quetta shifted to Karachi
International symposium highlights undeniable benefits of robotic surgery
Quetta: Doctor infected with congo virus dies on his way to Karachi
Week-long polio campaign to kick-off in Karachi
Healthcare events to be held in Dubai from October 31 to Nov 2
Next Article
Exit mobile version